RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer
2008-01-01 Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C
A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer.
2014-01-01 Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
2020-01-01 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
2013-01-01 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
A pilot analysis of headache disorders in breast cancer patients
2021-01-01 De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando
A prospective observational study to evaluate G-CSF usage inpatients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.
2014-01-01 Barni, S; Lorusso, V; Giordano, M; Sogno, G; Gamucci, T; Santoro, A; Passalacqua, R; Iaffaioli, V; Zilembo, N; Mencoboni, M; Roselli, M; Pappagallo, G; Pronzato, P
A prospective study on survival in cancer patients with and without venous thromboembolism
2013-01-01 Agnelli, G; Verso, M; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino, L; Labianca, R
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
2001-01-01 Gortzak, E; Azzarelli, A; Buesa, J; Bramwell, Vhc; van Coevorden, F; van Geel, An; Ezzat, A; Santoro, A; Oosterhuis, Jw; van Glabbeke, M; Kirkpatrick, A; Verweij, J
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
2009-01-01 Ychou, M.; Hohenberger, W.; Thezenas, S.; Navarro, M.; Maurel, J.; Bokemeyer, C.; Shacham-Shmueli, E.; Rivera, F.; Choi C., Kwok-Keung; Santoro, A
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial
2009-01-01 Infante, M.; Cavuto, S.; Lutman, F. R.; Brambilla, G.; Chiesa, G.; Ceresoli, G.; Passera, E.; Angeli, E.; Chiarenza, M.; Aranzulla, G.; Cariboni, U.; Errico, V.; Inzirillo, F.; Bottoni, E.; Voulaz, E.; Alloisio, M.; Destro, A.; Roncalli, M.; Santoro, A.; Ravasi, G.; Study Group, Dante
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer | 1-gen-2008 | Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C | |
| A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer. | 1-gen-2014 | Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C | |
| A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma | 1-gen-2020 | Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A | |
| A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | 1-gen-2013 | Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J | |
| A pilot analysis of headache disorders in breast cancer patients | 1-gen-2021 | De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando | |
| A prospective observational study to evaluate G-CSF usage inpatients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice. | 1-gen-2014 | Barni, S; Lorusso, V; Giordano, M; Sogno, G; Gamucci, T; Santoro, A; Passalacqua, R; Iaffaioli, V; Zilembo, N; Mencoboni, M; Roselli, M; Pappagallo, G; Pronzato, P | |
| A prospective study on survival in cancer patients with and without venous thromboembolism | 1-gen-2013 | Agnelli, G; Verso, M; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino, L; Labianca, R | |
| A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma | 1-gen-2001 | Gortzak, E; Azzarelli, A; Buesa, J; Bramwell, Vhc; van Coevorden, F; van Geel, An; Ezzat, A; Santoro, A; Oosterhuis, Jw; van Glabbeke, M; Kirkpatrick, A; Verweij, J | |
| A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer | 1-gen-2009 | Ychou, M.; Hohenberger, W.; Thezenas, S.; Navarro, M.; Maurel, J.; Bokemeyer, C.; Shacham-Shmueli, E.; Rivera, F.; Choi C., Kwok-Keung; Santoro, A | |
| A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial | 1-gen-2009 | Infante, M.; Cavuto, S.; Lutman, F. R.; Brambilla, G.; Chiesa, G.; Ceresoli, G.; Passera, E.; Angeli, E.; Chiarenza, M.; Aranzulla, G.; Cariboni, U.; Errico, V.; Inzirillo, F.; Bottoni, E.; Voulaz, E.; Alloisio, M.; Destro, A.; Roncalli, M.; Santoro, A.; Ravasi, G.; Study Group, Dante |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 827
- 1 Contributo su Rivista::1.1 Arti... 734
- 1 Contributo su Rivista::1.5 Abst... 84
- 1 Contributo su Rivista::1.2 Rece... 6
- 1 Contributo su Rivista::1.7 Lettera 3
Data di pubblicazione
- In corso di stampa 5
- 2020 - 2024 199
- 2010 - 2019 372
- 2000 - 2009 166
- 1990 - 1999 52
- 1982 - 1989 33
Rivista
- ANNALS OF ONCOLOGY 85
- JOURNAL OF CLINICAL ONCOLOGY 67
- BONE MARROW TRANSPLANTATION 31
- EUROPEAN JOURNAL OF CANCER 22
- BLOOD 19
- THE LANCET ONCOLOGY 19
- HAEMATOLOGICA 15
- LUNG CANCER 15
- CANCERS 14
- BRITISH JOURNAL OF CANCER 13
Keyword
- Humans 29
- Female 15
- Middle Aged 13
- Male 12
- Adult 10
- Aged 10
- COVID-19 10
- immunotherapy 10
- breast cancer 9
- Antineoplastic Agents 8
Lingua
- eng 489
- ita 2
Accesso al fulltext
- no fulltext 625
- reserved 189
- open 13